Efficacy and safety of eltrombopag in combination with dexamethasone as first-line treatment in adult patients with newly diagnosed immune thrombocytopenia for the British Journal of Haematology

Schmidt-Barbo P, Schultheiss C, Hänel M, Chromik J, Stauch T, Trautmann-Grill K, Repp R, Schulte C, Fleischmann B, Welslau M, Stauch M, Quiering C, Richter F, Tesanovic T, Jahn S, Bignucolo O, Holbro A, Passweg JR, Matzdorff A, Meyer O, Nimmerjahn F, Binder M (2026)


Publication Type: Journal article

Publication year: 2026

Journal

DOI: 10.1111/bjh.70312

Authors with CRIS profile

Involved external institutions

How to cite

APA:

Schmidt-Barbo, P., Schultheiss, C., Hänel, M., Chromik, J., Stauch, T., Trautmann-Grill, K.,... Binder, M. (2026). Efficacy and safety of eltrombopag in combination with dexamethasone as first-line treatment in adult patients with newly diagnosed immune thrombocytopenia for the British Journal of Haematology. British Journal of Haematology. https://doi.org/10.1111/bjh.70312

MLA:

Schmidt-Barbo, Paul, et al. "Efficacy and safety of eltrombopag in combination with dexamethasone as first-line treatment in adult patients with newly diagnosed immune thrombocytopenia for the British Journal of Haematology." British Journal of Haematology (2026).

BibTeX: Download